Alba Pau-Parra

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)AllergyNutrigenomics and personalised nutritionToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2025
Use of Dasatinib for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome After Axicabtagene Ciloleucel Infusion: A Case Report.

Jaime Llata-Ortega, Alba Pau-Parra, Carla Alonso-Martínez

|Jun 25, 2025
Pharmacokinetics of Isavuconazole During Extracorporeal Membrane Oxygenation Support in Critically Ill Patients: A Case Series.

Laura Doménech-Moral, Sonia García-García, Alba Pau-Parra

|Jan 20, 2025
Therapeutic drug monitoring-guided high-dose isavuconazole therapy for invasive pulmonary aspergillosis in a patient on extracorporeal membrane oxygenation support.

Alba Pau-Parra, Manuel Sosa Garay, Laura Doménech Moral

|Sep 28, 2024
Impact of Omega-3 Fatty Acid Supplementation in Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill COVID-19 Patients: A Randomized Controlled Trial.

David Berlana, Raquel Albertos, Raquel Barquin

|Apr 13, 2024
Comparing Aluminum Concentrations in Adult and Pediatric Parenteral Nutrition Solutions: Multichamber-Bag versus Compounded Parenteral Nutrition.

David Berlana, Juan López-Hellín, Alba Pau-Parra

|May 12, 2023
Ertapenem blood concentration: A retrospective cohort study to analyse risk of neurotoxicity.

David Campany-Herrero, Alba Pau-Parra, Pablo González-Moreno

Pageof 2

Frequent Collaborators

2 joint publications

Jordi Riera

2 joint publications

David Berlana

1 joint publications

David Campany-Herrero

1 joint publications

Rocío López-Martínez